DVA
65
3
STX
35
4
AMZN
44
2
IR
57
17
KEY
33
2
KMB
36
8
WY
33
2
DTE
31
2
A
30
4
MCD
57
2
CAG
44
3
SLB
38
6
IRM
41
7
MA
57
7
CME
56
14
VRSK
63
9
EXR
22
-13
ZTS
16
6
VRTX
49
3
AIV
30
4
DVA
65
3
STX
35
4
AMZN
44
2
IR
57
17
KEY
33
2
KMB
36
8
WY
33
2
DTE
31
2
A
30
4
MCD
57
2
CAG
44
3
SLB
38
6
IRM
41
7
MA
57
7
CME
56
14
VRSK
63
9
EXR
22
-13
ZTS
16
6
VRTX
49
3
AIV
30
4
Financhill
Back

Bicara Therapeutics Vs. Progress Software Industry Stock Comparison

Sell
28

BCAX
Bicara Therapeutics

Last Price:
$10.77
Seasonality Move:
--
Buy
55

PRGS
Progress Software

Last Price:
$57.67
Seasonality Move:
0.34%
Sell
28
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $10.77. The Score for BCAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Progress Software (PRGS) is a Buy

Is Progress Software a Buy, Sell or Hold?

  • The current Progress Software [PRGS] share price is $57.70. The Score for PRGS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • PRGS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $10.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRGS Stock Price Chart

What is Progress Software's stock price today?

  • The Progress Software share price today is $57.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.85 Sell
Relative Strength Index (14 RSI): 41.71 Sell
Chaikin Money Flow: 268151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.91 - 14.11) Sell
Bollinger Bands (100): (11.72 - 18.2) Sell

PRGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.31 Buy
Relative Strength Index (14 RSI): 55.54 Buy
Chaikin Money Flow: 475028 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.6 - 57.26) Buy
Bollinger Bands (100): (55.01 - 66.37) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.73 Buy
20-day SMA: 12.15 Sell
50-day SMA: 12.77 Sell
200-day SMA: 0 Buy
8-day EMA: 10.81 Sell
20-day EMA: 11.78 Sell
50-day EMA: 12.87 Sell
200-day EMA: 11.3 Sell

PRGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.02 Buy
20-day SMA: 55.49 Buy
50-day SMA: 55.96 Buy
200-day SMA: 60.08 Sell
8-day EMA: 56.6 Buy
20-day EMA: 55.98 Buy
50-day EMA: 56.82 Buy
200-day EMA: 58.78 Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.

Progress Software Earnings Growth & PRGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.11 per share, an increase this year of $0.48 per share, and an increase next year of $0.54 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Progress Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):